The Patent Finder

Terms ending in 2030

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,546,410Heteroaryl-Fused Macrocyclic Pyrimidine Derivatives
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US D746,871Interface Portion of a Pump
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,394,363Antibodies to Receptor of Advanced Glycation End Products (RAGE) and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,035,027Dual Variable Domain Immunoglobulins and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,420,081Antibody Formulations and Methods of Making Same
In force
 · High confidence
AbbVie Biotechnology Ltd.In forceHigh confidence
US 8,404,719Substituted Piperidinylcarbonylbenzenesulfonamides as Calcium Channel Blockers
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,093,396Benzthiazole Inhibitors of Poly(ADP-RIBOSE)polymerase
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,603,477Use of ANTI-CS1 Antibodies for Treatment of Rare Lymphomas
In force
 · High confidence
Abbott Biotherapeutics Corp.In forceHigh confidence
US 9,353,091Antiviral Compounds and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,637,478Antiviral Compounds and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
48 more term ends in 2030 · Pro
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
Upgrade to Pro
57 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited